4.8 Article

Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

期刊

NATURE METHODS
卷 12, 期 12, 页码 1143-+

出版社

NATURE PORTFOLIO
DOI: 10.1038/nmeth.3630

关键词

-

资金

  1. US National Institutes of Health (NIH) [R01DA036865, U01HG007900, R21AR065956, P30AR066527]
  2. NIH [DP20D008586]
  3. US National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award [CBET-1151035]
  4. American Heart Association Scientist Development grant [10SDG3060033]
  5. NSF
  6. American Heart Association
  7. Directorate For Engineering
  8. Div Of Chem, Bioeng, Env, & Transp Sys [1151035] Funding Source: National Science Foundation

向作者/读者索取更多资源

Epigenome editing with the CRISPR (clustered, regularly interspaced, short palindromic repeats)-Cas9 platform is a promising technology for modulating gene expression to direct cell phenotype and to dissect the causal epigenetic mechanisms of gene regulation. Fusions of nuclease-inactive dCas9 to the Kruppel-associated box (KRAB) repressor (dCas9-KRAB) can silence target gene expression, but the genome-wide specificity and the extent of heterochromatin formation catalyzed by dCas9-KRAB are not known. We targeted dCas9-KRAB to the HS2 enhancer, a distal regulatory element that orchestrates the expression of multiple globin genes, and observed highly specific induction of H3K9 trimethylation (H3K9me3) at the enhancer and decreased chromatin accessibility of both the enhancer and its promoter targets. Targeted epigenetic modification of HS2 silenced the expression of multiple globin genes, with minimal off-target changes in global gene expression. These results demonstrate that repression mediated by dCas9-KRAB is sufficiently specific to disrupt the activity of individual enhancers via local modification of the epigenome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据